Table S1.
Formulation | Antigen dose (μg) | Volume (μL) | Immunization schedule (days) | Serum (days) | Saliva, vaginal fluid (days) | Immunocytes (splenocytes, macrophages) (days) |
---|---|---|---|---|---|---|
PBS | 0 | 20 | 1, 15, 29 | 14, 28, 42 | 42 | 42 |
Ova | 20 | 20 | 1, 15, 29 | 14, 28, 42 | 42 | 42 |
Ova + AL | 20 | 20 | 1, 15, 29 | 14, 28, 42 | 42 | 42 |
Ova + CS | 20 | 20 | 1, 15, 29 | 14, 28, 42 | 42 | 42 |
Ova + O-HTCC | 20 | 20 | 1, 15, 29 | 14, 28, 42 | 42 | 42 |
CS + O-HTCC | 0 | 20 | 1, 15, 29 | 14, 28, 42 | 42 | 42 |
Ova/CS/O-HTCC | 20 | 20 | 1, 15, 29 | 14, 28, 42 | 42 | 42 |
Abbreviations: CS, curdlan sulfate; O-HTCC, O-(2-hydroxyl)propyl-3-trimethyl ammonium chitosan chloride; Ova, ovalbumin; AL, Alhydrogel.